2007
DOI: 10.1016/j.trim.2007.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Activation of PPARγ enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
5
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 36 publications
1
5
0
Order By: Relevance
“…However, the role of Pcgf4 and Ybx1 in nephrotoxicity has not yet been fully evaluated. It has been shown that Il-2 is down-regulated in Cisplatin and Cyclosporine nephrotoxicity [51,52]. Consistent with these studies, we found Il-2 as a common hub gene in Cisplatin, Lead acetate and Cyclosporine nephrotoxicity.…”
Section: Discussionsupporting
confidence: 91%
“…However, the role of Pcgf4 and Ybx1 in nephrotoxicity has not yet been fully evaluated. It has been shown that Il-2 is down-regulated in Cisplatin and Cyclosporine nephrotoxicity [51,52]. Consistent with these studies, we found Il-2 as a common hub gene in Cisplatin, Lead acetate and Cyclosporine nephrotoxicity.…”
Section: Discussionsupporting
confidence: 91%
“…Apparently, the amelioration of the CSA-evoked lipid peroxidation, oxidative stress, and dyslipidemia contributes to the inhibitory effect of pioglitazone on the CSA-evoked hypertension. The clinical importance of this research is warranted particularly in view of recent information that the activation of PPARγ boosts the immunosuppressant effect of CSA via the inhibition of T cell proliferation and IL-2 release [43]. Interestingly, the combined use of PPARγ ligands and low-dose CSA might represent a rationale therapeutic approach for the prevention of CSA nephrotoxicity while maintaining adequate immunosuppression [43,44].…”
Section: Discussionmentioning
confidence: 99%
“…In adipocytes, PPARg activates the expression of a variety of beneficial cell factors such as resistin, IL-6, and TNFα (Sharma and Staels, 2007;Qin et al, 2008), as well as plays multiple roles in glucose and lipid metabolism, atherosclerosis, and inflammatory responses (Tontonoz et al, 1995;Li et al, 2000;Fernyhough et al, 2007;Széles et al, 2007;Rampino et al, 2007). PPARg is involved in the regulation of the expression of lipid metabolism-related genes, which can promote adipocyte differentiation, and a number of protein factor genes secreted by adipocytes, such as lipoprotein lipase, the fatty acid binding protein, acetyl CoA synthetase, and glucose transporter 4.…”
Section: Discussionmentioning
confidence: 99%